Cary, NC, United States of America

Neil A Castle

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Gfb (Abc), LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil A Castle. Retrieved from https://idiyas.com/inventor/neil-a-castle-3bmjzy14

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil A Castle: Innovator in Pharmaceutical Compounds

Introduction

Neil A Castle is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Neil A Castle holds 1 patent for his invention titled "Imidazodiazepinediones and methods of use thereof." This patent discloses compounds according to Formula (I) or (II), along with pharmaceutical compositions that comprise them. The invention also outlines therapeutic methods for treating kidney diseases using these compounds.

Career Highlights

Neil is currently associated with GFB (ABC), LLC, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in developing new compounds has positioned him as a valuable asset in his field.

Collaborations

Neil collaborates with Matthew H Daniels, contributing to the advancement of their projects and enhancing the research capabilities of their team.

Conclusion

Neil A Castle's work in pharmaceutical innovations demonstrates his commitment to improving health outcomes through scientific advancements. His contributions are paving the way for new therapeutic methods in treating kidney diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…